StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) income statement

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.89+0.18 (+10.53%)

Close on Nov 18, 2026Market cap $3.00MP/E –Yield –

Silo Pharma, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
-14.8%
Operating margin
-8250.5%
Net margin
-8269.5%
Return on equity, FY2025
-74.6%

Financial strength

Current ratio
5.36
Debt to equity
–
Debt to assets
–
Cash to current liabilities
307.5%

Valuation

P/E ratio
–
Price to sales
55.51
Price to book
0.61
Dividend yield
–

See a number that looks wrong?